Zu "K19722" wurden 139 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
NEU
RAGE Protein, Human, Recombinant (Avi & hFc), Biotinylated
Artikelnummer: TGM-TMPY-07069-100ug
Description: RAGE Protein, Human, Recombinant (Avi & hFc), Biotinylated is expressed in HEK293 Cells. The accession number is Q15109.
| Schlagworte: | sRAGE , AGER , SCARJ1 , RAGE |
| MW: | 62.71 kD |
ab 196,00 €
Anti-Recombinant RAGE, clone 2B13
Artikelnummer: E-AN300605L.100
The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as...
| Schlagworte: | Anti-AGER, Anti-Receptor for advanced glycosylation end products, Anti-Advanced glycosylation end product-specific... |
| Anwendung: | WB |
| Wirt: | Rabbit |
| Spezies-Reaktivität: | human, mouse, rat |
ab 258,00 €
Mouse RAGE ELISA Kit
Artikelnummer: ARG81753.96
Protein function: Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as...
| Schlagworte: | Ager, Rage, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor |
| Anwendung: | ELISA |
| Spezies-Reaktivität: | mouse |
1.118,00 €
Human RAGE ELISA Kit
Artikelnummer: ARG81343.96
Protein function: Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as...
| Schlagworte: | AGER, RAGE, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor |
| Anwendung: | ELISA |
| Spezies-Reaktivität: | human |
719,00 €
AGER, His, Human
Artikelnummer: GSC-Z04999-100
The receptor for advanced glycation end products (AGER) is an oncogenic transmembranous receptor up-regulated in various human cancers. AGER promotes proliferation, migration, and inhibits apoptosis of squamous cervical cancer and might function as a tumor promoter in cervical cancer. Our study provides novel...
| Schlagworte: | AGER, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor |
| Ursprungsart: | human |
| MW: | 35.3 kD |
ab 457,00 €
AGER, His, Mouse
Artikelnummer: GSC-Z05990-100
The receptor for advanced glycation end products (AGER) is an oncogenic transmembranous receptor up-regulated in various human cancers. AGER promotes proliferation, migration, and inhibits apoptosis of squamous cervical cancer and might function as a tumor promoter in cervical cancer. Our study provides novel...
| Schlagworte: | Ager, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor |
| Ursprungsart: | mouse |
| MW: | 35 kD |
ab 457,00 €
AGER, His, Mouse
Artikelnummer: GSC-Z05989-100
The receptor for advanced glycation end-products (RAGE) is a cell surface transmembrane multiligand receptor, encoded by the AGER gene. RAGE presents many transcripts, is expressed mainly in the lung, and involves multiple pathways (such as NFkappaB, Akt, p38, and MAP kinases) that initiate and perpetuate an...
| Schlagworte: | Ager, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor |
| Ursprungsart: | mouse |
| MW: | 34.85 kD |
ab 430,00 €
Nepsilon-(1-Carboxymethyl)-L-lysine
Artikelnummer: Cay16483-1
Nepsilon-(1-Carboxymethyl)-L-lysine (CML) is an advanced glycation end product (AGE), produced by the oxidative modification of glycated proteins during oxidative stress. Levels of CML increase with aging and during diabetes, cancer, vascular disease, and other pathologies marked by oxidative stress. CML activates...
| Schlagworte: | CML, N6-(carboxymethyl)-L-lysine |
| Anwendung: | Advanced glycation endproduct (AGE), AGER/RAGE ligand |
| CAS | 5746-04-3 |
| MW: | 204.2 D |
ab 83,00 €
Ager (mouse), recombinant protein (His Tag)
Artikelnummer: E-PDMM100050.1
Protein function: Cell surface pattern recognition receptor that senses endogenous stress signals with a broad ligand repertoire including advanced glycation end products, S100 proteins, high-mobility group box 1 protein/HMGB1, amyloid beta/APP oligomers, nucleic acids, histones, phospholipids and glycosaminoglycans...
| Schlagworte: | Ager, Rage, Receptor for advanced glycosylation end products, Advanced glycosylation end product-specific receptor,... |
| Exprimiert in: | Mammalian |
| Ursprungsart: | mouse |
ab 192,00 €
Nepsilon-(1-Carboxyethyl)-L-lysine
Artikelnummer: Cay25333-1
Nepsilon-(1-Carboxyethyl)-L-lysine (CEL) is an advanced glycation end product (AGE) produced by the reaction of methyl glyoxal with lysine residues in proteins. Protein bound, but not free, CEL binds to the receptor for AGEs (RAGE). CEL levels are elevated in the lens of diabetic patients with cataract. Long-term...
| Schlagworte: | CEL, N6-(1-carboxyethyl)-L-lysine |
| Anwendung: | Advanced glycation end product (AGE) |
| CAS | 5746-03-2 |
| MW: | 218.3 D |
ab 56,00 €
Nepsilon-(1-Carboxymethyl)-L-lysine-d3
Artikelnummer: Cay26785-1
Nepsilon-(1-Carboxymethyl)-L-lysine-d3 (CML-d3) is intended for use as an internal standard for the quantification of CML (Cay-16483) by GC- or LC-MS. CML is an advanced glycation end product (AGE), produced by the oxidative modification of glycated proteins during oxidative stress. Levels of CML increase with aging...
| Schlagworte: | CML-d3, N6-(carboxymethyl)-L-lysine-2,6,6-d3 |
| Anwendung: | GC-MS, LC-MS, quantification, internal standard, Advanced glycation endproduct (AGE), AGER/RAGE ligand |
| CAS | 2699607-49-1 |
| MW: | 207.2 D |
ab 290,00 €
CEL-BSA
Artikelnummer: Cay22973-200
Advanced glycation end products (AGEs) are formed from the nonenzymatic reaction of amino groups with reducing sugars. AGEs have been implicated in diseases, such as diabetes mellitus, non-diabetic nephropathy, macrovascular disease, Alzheimer's disease, cataract, and ageing. AGE receptors, such as the receptor for...
| Schlagworte: | Nepsilon-(1-Carboxyethyl)-L-lysine-Bovine Serum Albumin, Nepsilon-(1-Carboxyethyl)-L-lysine-BSA |
| Anwendung: | Synthetic advanced glycation end product (AGE), RAGE ligand |
274,00 €